Source: Instrument Family, unauthorized reproduction is prohibited, and reproduction is allowed 24 hours later.

Recently, the Instrument Family learned that,Medtronic (NYSE: MDT) has entered into a deep collaboration with Methinks AI, which focuses on artificial intelligence medical applications.Aiming to bring higher-quality treatment services to stroke patients in multiple regions, including Central and Eastern Europe, Africa, Turkey, and the Middle East, helping to achieve a leapfrog improvement in local stroke treatment standards.Methinks AI has a close cooperative relationship with the tech giant Microsoft.

01

Focus on Neurovascular

Strengthen Stroke Care Services

This deep collaboration with Methinks AI focuses on Medtronic's highly influential neurovascular business segment.Although the two parties did not disclose specific financial terms, this cooperation is of extraordinary significance from a strategic perspective. Medtronic emphasized that this collaboration highlights the critical role of services and solutions in optimizing stroke care, particularly in terms of surgical support and improving patient treatment pathways.

Methinks AI, an emerging company in the field of artificial intelligence healthcare, has injected new vitality into stroke treatment with its advanced artificial intelligence-driven radiology triage and notification system. This system utilizes artificial intelligence algorithms to quickly and accurately analyze and evaluate patients' imaging data, providing doctors with timely and effective diagnostic support, thereby enhancing the precision and timeliness of stroke treatment.

This collaboration with Methinks AI is not Medtronic's first innovative step in the field of stroke treatment. Earlier this year, Medtronic partnered with Brainomix, aiming to enhance stroke patient care in Western Europe. Brainomix and Medtronic plan to deeply integrate artificial intelligence solutions into clinical practice, expanding access to transformative therapies so that more patients can benefit from advanced medical technologies.

Meanwhile, Methinks AI itself is also continuously expanding its cooperative boundaries,Established a close cooperative relationship with tech giant Microsoft. Leveraging Microsoft's robust technical capabilities and extensive resource network,Methinks AI's technical scalability and accessibility have been significantly enhanced, with the potential to provide high-quality medical services to more healthcare institutions and patients worldwide.

One of the highlights of Methinks AI's solutions——More than 80% of large vessel occlusions can be detected using non-enhanced CT imaging alone.This technological breakthrough is significant because not all medical institutions in real-world healthcare settings are equipped with advanced high-end imaging technology devices. Methinks AI's solution breaks this limitation, enabling faster condition assessment even in medical environments with limited high-end imaging technology. This helps save precious treatment time for patients and improves their survival rate and quality of life.

Medtronic has high hopes for this collaboration, believing it can streamline the connection between stroke centers and regional hospitals, enabling seamless triage and care coordination. By deeply integrating artificial intelligence technology with Medtronic’s existing medical products, there is potential to accelerate the widespread adoption of advanced treatment methods while improving overall treatment efficiency and reducing healthcare costs.

Maria Zvereva, Head of Neurovascular Strategic Marketing for Medtronic Central and Eastern Europe, stated: "At Medtronic, we consistently uphold the concept of innovation and are committed to providing creative solutions that go beyond traditional product offerings. This collaboration with Methinks AI further strengthens our steadfast commitment to offering advanced stroke care tools to healthcare professionals. We firmly believe that by combining breakthrough artificial intelligence evaluation technology with world-class medical device solutions, we can truly transform the current state of stroke care, ensuring patients in the region receive faster and more effective treatment, bringing new hope for their health."

02

Methinks AI: Empowering Stroke Diagnosis and Treatment with AI

In the wave of innovation in the digital health field, Methinks AI, headquartered in Barcelona, Spain, is bringing new hope to the diagnosis and treatment of stroke patients with its unique technology and products. Founded in 2016, this startup focuses on developing medical imaging software for early stroke assessment using artificial intelligence (AI) technology. It is committed to optimizing the triage process for stroke patients through fast and accurate diagnostic tools, reducing treatment time, and thereby improving clinical outcomes.

Methinks AI's core product, Methinks Stroke Suite, is a groundbreaking medical imaging software capable of accurately detecting large vessel occlusion (LVO) and intracerebral hemorrhage from non-contrast CT scans. This product boasts several notable features:

• High Sensitivity and Specificity: In detecting large vessel occlusion, its sensitivity reaches 87.2%, and specificity is 87.7%, providing doctors with a reliable diagnostic basis.
• 
  
• Rapid Diagnosis:Without the need for contrast-enhanced CT or MRI, stroke patients can be quickly identified, significantly reducing diagnosis time and saving precious treatment opportunities for patients.
• 
  
• Cloud Platform Integration:Deeply integrated with Microsoft Azure and Microsoft Teams, healthcare professionals can view AI analysis results and medical images in real time on the cloud platform, enabling efficient information sharing and collaboration.
• 
  

Methinks AI's collaboration with Microsoft is a remarkable example in the field of medical technology. The two parties have engaged in in-depth cooperation at multiple levels:

• Technology Integration: With the help of Microsoft's Azure cloud platform, the scalability and accessibility of Methinks AI's technology have been significantly enhanced. The powerful computing and data processing capabilities of the Azure platform enable Methinks AI's solutions to process and analyze medical images more efficiently, providing doctors with faster and more accurate diagnostic results.
• 
  
• Microsoft Teams Integration: Methinks AI's application is deeply integrated with Microsoft Teams, allowing healthcare professionals to directly receive real-time AI analysis results and medical images within Teams, eliminating the need to switch between different systems, significantly improving the efficiency of diagnosis and treatment.
• 
  
• Market Promotion: Microsoft's global influence and extensive customer base provide Methinks AI with broader market opportunities. Through collaboration with Microsoft, Methinks AI can promote its technology to more medical institutions and regions, especially in the healthcare sector, further expanding its market share.
• 
  

This cooperation is of great significance. On the one hand, it improves the efficiency of medical services, allowing medical professionals to diagnose strokes more quickly, reduce treatment delays, and provide patients with more opportunities for recovery. On the other hand, Microsoft's technical support enables Methinks AI's solutions to be more widely applied across different regions and medical institutions, especially in resource-limited environments, allowing more patients to benefit from advanced medical technologies.

03

Medtronic AI Strategic Layout

Medtronic, as a global leading medical technology company, has carried out extensive strategic layouts in the artificial intelligence (AI) field, aiming to enhance the performance of medical devices, optimize patient care processes, and promote the digital transformation of the healthcare industry through AI technology. The following are Medtronic's main layouts and progress in artificial intelligence:

Application Fields of AI Technology

• Robotic-Assisted Surgery Platform:Medtronic Applies AI Technology to Its Robot-Assisted Surgical Systems, Such as the Hugo Soft Tissue Robotic Platform and the Mazor Spine Surgery Navigation System.These systems provide real-time surgical guidance and decision support to surgeons through AI algorithms, improving surgical efficiency and patient outcomes.
• 
  
• Endoscopy and Colonoscopy Systems:Medtronic Collaborates with Cosmo Intelligent Medical Devices to Integrate AI Technology into the GI Genius™ Intelligent Endoscopy Module.The system uses machine learning to detect polyps and suspected tumors in real time during colonoscopy, significantly improving the detection rate of lesions.
• 
  
• Diabetes Management Device: Medtronic's MiniMed 780G Insulin Pump System uses AI algorithms to analyze blood glucose level trends and automatically adjusts insulin infusion rates, helping Type 1 diabetes patients achieve better blood glucose control.
• 
  
• Cardiac Monitoring Device: Medtronic's LINQ II Implantable Cardiac Monitor detects atrial fibrillation through the AccuRhythm AI algorithm, reducing false alarms and improving diagnostic accuracy.

Strategic Partnership

• Collaboration with Methinks AI: Medtronic and Methinks AI have reached a strategic partnership to integrate Methinks AI's stroke detection software with Medtronic's stroke treatment devices, optimizing the triage process and care coordination for stroke patients.
• 
  
• Collaboration with Cosmo Pharmaceuticals: Medtronic Expands Partnership with Cosmo, Paying $100 Million Upfront and Planning to Pay up to $100 Million in Future Milestone Payments for Global Exclusive Distribution Rights to the GI Genius™ Platform. The platform is not only used for real-time lesion detection but also planned to integrate third-party AI applications, further expanding the use of AI in endoscopy.
• 
  
• Collaboration with Nvidia: Medtronic collaborates with Nvidia to integrate Nvidia's Holoscan video processing software and IGX edge computing hardware into the GI Genius™ platform, enhancing the performance of AI applications.

Establishment of AI-related centers and innovation bases

• Medtronic Establishes AI Center of Excellence to Centralize Management of Key Data Assets, Including Clinical Data from Millions of Patients, Regulatory Expertise, Analytical Capabilities, and Medical Device Knowledge. Leveraging AI Technology, Medtronic Aims to Further Optimize Clinical Decision Support, Develop New Treatment Indications, and Offer Personalized Treatment Solutions.
• 
  
• In March 2025, the signing and unveiling ceremony of Medtronic's Digital Healthcare Innovation Hub was held at the International Pharmaceutical Innovation Park (BioPark) located in Beijing's Yizhuang New City. This hub is the first digital healthcare innovation base established by Medtronic in China. Medtronic's Digital Healthcare Innovation Hub is committed to developing disease management solutions based on artificial intelligence and big data. It will focus on building medical training centers in fields such as cardiovascular, minimally invasive surgery, and neuroscience; establish a patient care center to introduce digital technologies and enhance service levels for preventive patient management; and construct the Medtronic Museum. The innovation hub is scheduled to officially commence operations by the end of this year.
• 
  

Medtronic's Strategic Layout in the AI Field Covers Multiple Medical Areas from Surgical Robots to Diabetes Management. Through this collaboration with Methinks AI, Medtronic has not only enhanced the intelligence level of its products but also promoted the digital transformation of the healthcare industry. These initiatives not only help improve medical efficiency and patient treatment outcomes but also lay a solid foundation for future medical technology innovation.